BioSpectrum Asia

Thermo Fisher, Qatar Genome Program collaborat­e to advance precision medicine

-

Thermo Fisher Scientific and Qatar Genome Program (QGP), a member of Qatar Foundation (QF), have partnered with the goal of accelerati­ng genomic research and clinical applicatio­ns of predictive genomics in Qatar as a step toward expanding the benefits of precision medicine across Arab population­s globally. Under the agreement, Thermo Fisher and Qatar Genome Program will develop an Axiom custom genotyping array for panArab population­s using whole genome sequencing data from 19 Arab countries. The array, with about 800,000 variants, aims to help drive scientific research and insights into conditions including diabetes, cardiovasc­ular and metabolic diseases, autism, inherited genetic disorders and cancer. Once available through Thermo Fisher’s global commercial channels in late 2022, the array is intended to provide a cost-effective alternativ­e to whole genome sequencing for Arab population­s, enabling increased diversity in large genome-wide studies.

 ?? ??

Newspapers in English

Newspapers from India